Vanderbilt University is collaborating to catalyze the development of early stage therapeutics discovered at Vanderbilt through a new Deerfield-affiliated entity, Ancora Innovation, LLC. Through Deerfield, an investment management firm committed to advancing health care, Ancora will provide up to $65M in initial funding over five years to support the commercialization of early stage therapeutic research at Vanderbilt University and Vanderbilt University Medical Center, with additional funding available to advance research that shows strong commercial potential.
